Braingaze
Matar├│
About Braingaze
Braingaze solves major challenges around cognitive disorders of the brain. We use a patented neuro-biomarker based on small involuntary eye movements. These are triggered by functional games, the resulting signal is analysed using algorithms trained by Deep Learning based on actual real patient / control cases. We adress pre-symptomatic stages of Alzheimer's disease and the most common child cognitive disorder ADHD. Our tools are on the market and covered by a CE Mark as a medical device. Our pipeline includes detection / diagnostic tools as well as digital therapy solutions that have shown to reduce symtoms by over 50%.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.6M
- Last round: Series Unknown (Mar 2024)
- Website: braingaze.com
- Phone: +34 93 169 65 72
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Predictive Analytics, Software
Social Profiles
Canonical: https://fsome.com/organization/braingaze-172453 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.